Cancers | Free Full-Text | Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
Estimating progression-free survival in patients with glioblastoma using routinely collected data | Journal of Neuro-Oncology
Progression-free survival. Progression-free survival was defined as the... | Download Scientific Diagram
ASCO 2023: The Relationship Between a Priori Defined Prognostic Risk Groups and Overall Survival in Men with mHSPC
27 Survival analysis | The Epidemiologist R Handbook
Cancers | Free Full-Text | Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
Clinical Trial Endpoints for Oncology Studies
Overall survival (OS) according to PD-L1 expression. OS was defined as... | Download Scientific Diagram
Measures of Cancer Survival
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Frontiers | Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 (“Oligometastatic”) and M2 (“Polymetastatic”) subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX | Anticancer Research
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases | Breast Cancer Research | Full Text
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
Quantification of measurable residual disease in patients with multiple myeloma based on the IMWG response criteria | Scientific Reports
Evaluation of the impact of thyroiditis development in patients receiving immunotherapy with programmed cell death-1 inhibitors - Matthew Lei, Angela Michael, Seema Patel, Ding Wang, 2019
Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
1413 The overall survival (OS) and progression-free survival (PFS) of hyperprogressive disease (HDP) in lung cancer patients | Journal for ImmunoTherapy of Cancer
A Possible Definition of Oligometastasis in Pancreatic Cancer and Associated Survival Outcomes | Anticancer Research
